![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessRB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Tyrosine kinase inhibitors are effective treatments for non-small-cell lung cancers (NSCLCs) with epidermal growth factor receptor (EGFR) mutations. However, relapse typically occurs after an average of 1 year of...
-
Article
Open AccessSoftware-based risk stratification of pulmonary adenocarcinomas manifesting as pure ground glass nodules on computed tomography
To assess the performance of the “Computer-Aided Nodule Assessment and Risk Yield” (CANARY) software in the differentiation and risk assessment of histological subtypes of lung adenocarcinomas manifesting as p...
-
Article
Open AccessAssessing invasiveness of subsolid lung adenocarcinomas with combined attenuation and geometric feature models
The aim of this study was to develop and test multiclass predictive models for assessing the invasiveness of individual lung adenocarcinomas presenting as subsolid nodules on computed tomography (CT). 227 lung...